av/tme-pharma-nv--big.svg

COM:TMEPHARMA

TME Pharma N.V.

  • Stock

EUR

Last Close

0.15

25/11 09:23

Market Cap

6.05M

Beta: -

Volume Today

744.63K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-13.79M
-
-16.12M
16.88%
-10.72M
33.48%
-5.39M
49.75%
-10.74M
99.24%
-860K
91.99%
-10.41M
1,110%
-14.45M
38.88%
-15.13M
4.66%
-6.74M
55.47%
depreciation and amortization
279K
-
218K
21.86%
340K
55.96%
29K
91.47%
23K
20.69%
47K
104.35%
63K
34.04%
66K
4.76%
92K
39.39%
144K
56.52%
deferred income tax
-7K
-
-76K
-
stock based compensation
54K
-
275K
409.26%
396K
-
396K
0%
107K
72.98%
162K
51.40%
475K
193.21%
589K
24%
change in working capital
467K
-
888K
90.15%
-877K
198.76%
65K
107.41%
320K
392.31%
-371K
215.94%
363K
197.84%
407K
12.12%
-720K
276.90%
236K
132.78%
accounts receivables
inventory
1K
-
25K
2,400%
13K
48%
accounts payables
421K
-
-580K
237.77%
other working capital
466K
-
863K
85.19%
-890K
203.13%
-371K
-
363K
197.84%
-14K
103.86%
-140K
900%
236K
268.57%
other non cash items
536K
-
1.26M
135.26%
2.27M
80.10%
662K
70.85%
6.07M
817.52%
-3.21M
152.83%
4.59M
243.16%
1.12M
75.56%
3.02M
169.10%
721K
76.14%
net cash provided by operating activities
-12.46M
-
-13.48M
8.21%
-8.99M
33.31%
-4.24M
52.88%
-4M
5.59%
-4.29M
7.15%
-5.22M
21.89%
-12.38M
137.00%
-12.14M
1.92%
-5.63M
53.59%
investments in property plant and equipment
-47K
-
-8K
82.98%
-21K
162.50%
-2K
90.48%
-9K
350%
-16K
77.78%
-39K
143.75%
-14K
64.10%
-21K
50%
-19K
9.52%
acquisitions net
purchases of investments
-5K
-
-4.50M
-
sales maturities of investments
131K
-
4.50M
-
other investing activites
1K
-
25K
-
75K
-
net cash used for investing activites
-41K
-
-8K
80.49%
4K
150%
124K
3,000%
66K
46.77%
-16K
124.24%
-39K
143.75%
-14K
64.10%
-21K
50%
-19K
9.52%
debt repayment
-305K
-
-671K
120%
-39.00K
-
common stock issued
7.54M
-
1M
86.73%
4.41M
341.40%
1.52M
65.61%
8.80M
479.51%
7.22M
17.94%
85K
98.82%
common stock repurchased
-17K
-
-146K
758.82%
-4K
-
-1K
75%
-29K
2,800%
-1K
96.55%
dividends paid
other financing activites
9.22M
-
16.73M
81.40%
-413K
102.47%
1.67M
503.63%
3.19M
91.24%
-121K
103.80%
5.39M
4,553.72%
4.28M
20.58%
7.23M
68.90%
3.31M
54.27%
net cash used provided by financing activities
8.92M
-
16.06M
80.08%
7.11M
55.73%
2.52M
64.53%
7.60M
201.55%
1.40M
81.62%
14.18M
915.18%
11.50M
18.93%
7.29M
36.64%
3.27M
55.17%
effect of forex changes on cash
49K
-
57K
16.33%
-1K
101.75%
net change in cash
-3.58M
-
2.57M
171.60%
-1.88M
173.23%
-1.59M
15.27%
3.67M
330.40%
-2.90M
179.20%
8.92M
407.02%
-848K
109.51%
-4.82M
468.63%
-2.39M
50.46%
cash at beginning of period
5.11M
-
1.53M
70.12%
4.09M
168.04%
2.21M
45.91%
622K
71.91%
4.29M
589.71%
1.39M
67.72%
10.30M
643.97%
9.46M
8.23%
4.63M
50.99%
cash at end of period
1.53M
-
4.09M
168.04%
2.21M
45.91%
622K
71.91%
4.29M
589.71%
1.39M
67.72%
10.30M
643.97%
9.46M
8.23%
4.63M
50.99%
2.25M
51.55%
operating cash flow
-12.46M
-
-13.48M
8.21%
-8.99M
33.31%
-4.24M
52.88%
-4M
5.59%
-4.29M
7.15%
-5.22M
21.89%
-12.38M
137.00%
-12.14M
1.92%
-5.63M
53.59%
capital expenditure
-47K
-
-8K
82.98%
-21K
162.50%
-2K
90.48%
-9K
350%
-16K
77.78%
-39K
143.75%
-14K
64.10%
-21K
50%
-19K
9.52%
free cash flow
-12.51M
-
-13.49M
7.87%
-9.01M
33.19%
-4.24M
52.96%
-4.01M
5.43%
-4.30M
7.31%
-5.26M
22.34%
-12.39M
135.51%
-12.16M
1.86%
-5.65M
53.52%

All numbers in EUR (except ratios and percentages)